Advertisement

Topics

The Medicines Company Company Profile

09:16 EST 12th December 2018 | BioPortfolio

The Medicines Company's purpose is to save lives, alleviate suffering and contribute to the economics of healthcare by focusing on 3000 leading acute/intensive care hospitals worldwide. Its vision is to be a leading provider of solutions in three areas: serious infectious disease care, acute cardiovascular care and surgery and perioperative care. The company operates in the Americas, Europe and the Middle East, and Asia Pacific regions with global centers today in Parsippany, NJ, USA and Zurich, Switzerland.


News Articles [424 Associated News Articles listed on BioPortfolio]

The Medicines Company to Announce Third-Quarter 2018 Financial Results on November 8

The Medicines Company (NASDAQ:MDCO) will host a conference call and audio webcast on Thursday, November 8, 2018, at 8:30 a.m., EST, to discuss its third-quarter 2018 financial res...

Company Profile for The Medicines Company

The Medicines Company is a biopharmaceutical company driven by an overriding purpose – to save lives, alleviate suffering and contribute to the economics of healthcare. The Comp...

The Medicines Company to Announce Second-Quarter 2018 Financial Results on August 1

The Medicines Company (NASDAQ:MDCO) will host a conference call and audio webcast on Wednesday, August 1, 2018, at 8:30 a.m. EDT to discuss its second-quarter 2018 financial resul...

News and press releases: Update on medicines containing valsartan from Zhejiang Tianyu

Company no longer authorised to manufacture valsartan active substance for EU medicines due to presence of NDMA

Former Merck, Purdue Pharma Exec Timney Named Medicines Company CEO

Mark Timney has been appointed CEO of The Medicines Company (NASDAQ: MDCO), effective immediately. Timney is also joining the Parsippany, NJ, company’s board of directors. Timney succeeds Clive Mean...

New antibiotic and migraine drug among 13 medicines recommended by EMA

The European Medicines Agency has recommended 13 medicines for approval, including three orphan medicines.

Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections

The Medicines Company exited the infectious disease business last year when it sold three bacteria-fighting products to Melinta Therapeutics. But Melinta didn’t get all of the company’s b...

Ongoing review of valsartan medicines reveals NDMA in medicines from second manufacturer

An ongoing review of valsartan medicines by the European Medicines Agency (EMA), has led to the detection of low level of nitrosodiumethylamine (NDMA) in medicines produced by another company, Zhejian...

Drugs and Medications [1391 Associated Drugs and Medications listed on BioPortfolio]

Cimetidine [Walgreen Company]

Walgreen Co. Cimetidine 200 Drug Facts

Qsr hand sanitizer [Kay Chemical Company]

Drug Facts

Terbinafine hydrochloride [Aurobindo Pharma Limited]

These highlights do not include all the information needed to use terbinafine hydrochloride safely and effectively. See full prescribing information for terbinafine hydrochloride tablets.Terbinafine H...

Conquest [KAY CHEMICAL CO.]

Drug Facts

Care one arthritis pain relief [American Sales Company]

American Sales Company Arthritis Pain Relief Drug Facts

PubMed Articles [255 Associated PubMed Articles listed on BioPortfolio]

Does consumer medicines interest reflect medicines use? An Australian observational study comparing medicines call center queries with medicines use.

Consumers have questions about their medication but the nature of these concerns and how they reflect medication use is unknown.

Characteristics of Occupational Injuries in a Pharmaceutical Company in Iran.

To prioritize occupational hazards in a Pharmaceutical Company in Iran using the analytical hierarchy process (AHP).

Adolescents' knowledge and perception of risk toward medicines.

Adolescents often start to use medicines independently without having sufficient knowledge or previous experience, which can lead to the inappropriate use of the medicines.

Lost medicines: a longer view of the pharmaceutical industry with the potential to reinvigorate discovery.

It is widely understood that the 1962 Kefauver-Harris Amendment to the Food, Drug and Cosmetics Act ushered in the modern regulation of medicines requiring a combination of safety and efficacy. Howeve...

Review: The Health Consequences of Falsified Medicines.

To analyse and present the literature describing the health consequences of falsified medicines, focusing on mortality and morbidity, as well as the scale of the issue, the geographic extent, the medi...

Clinical Trials [536 Associated Clinical Trials listed on BioPortfolio]

Epidemiology of Cardiovascular and Non-Cardiovascular Risk In Chicago

To continue the comprehensive research program on the epidemiology of cardiovascular and other major chronic diseases, including cancer and diabetes, in four Chicago population cohorts. T...

Immunogenicity and Safety of Kinrix + MMR With and Without Varicella Vaccine in Healthy Children 4-6 Years

The purpose of the study is to evaluate the immunogenicity and safety of Kinrix when co-administered with varicella (Varivax® [varicella virus vaccine live], Merck and Company) and MMR va...

Tuberculosis Treatment Shortening Trial

Tuberculosis (TB) is a serious infection that can affect the lungs and other parts of the body. The usual way to treat TB is to take 4 medicines by mouth every day for 2 months, then take ...

A Double-blind Randomized Placebo-controlled Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Atherosclerotic Cardiovascular Disease

ORION-4 is a research study coordinated by the University of Oxford and co-sponsored by The University of Oxford and The Medicines Company. The study aims to find out if a new cholesterol-...

Medicines Reconciliation at an Intensive Care Unit

This study evaluates the effect of performing medicines reconciliation on patients admitted to an intensive care unit. Half of the patients will receive a medicines reconciliation at the i...

Companies [2012 Associated Companies listed on BioPortfolio]

Ligand Pharmaceuticals Incorporated and The Medicines Company

The Medicines Company (NASDAQ: MDCO) provides medical solutions to improve health outcomes for patients in acute and intensive care hospitals worldwide. These solutions comprise m...

AstraZeneca and The Medicines Company

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialization of prescription medicines for gastro...

The Medicines Company and Alnylam Pharmaceuticals, Inc.

The Medicines Company is a biopharmaceutical company driven by an overriding purpose – to save lives, alleviate suffering and contribute to the economics of healthcare. The C...

Alphapharm

Alphapharm is one of Australia's leading pharmaceutical companies. We develop, manufacture, market and distribute prescription medicines and medicines only available at pharmacies. Our speciality is b...

The Medicines Company

The Medicines Company's purpose is to save lives, alleviate suffering and contribute to the economics of healthcare by focusing on 3000 leading acute/intensive care hospital...

More Information about "The Medicines Company" on BioPortfolio

We have published hundreds of The Medicines Company news stories on BioPortfolio along with dozens of The Medicines Company Clinical Trials and PubMed Articles about The Medicines Company for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Medicines Company Companies in our database. You can also find out about relevant The Medicines Company Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record